European Urology Oncology

Slides:



Advertisements
Similar presentations
The PSA Era is not Over for Prostate Cancer
Advertisements

Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
Volume 64, Issue 3, Pages (September 2013)
Volume 58, Issue 4, Pages (October 2010)
Volume 62, Issue 5, Pages (November 2012)
Volume 60, Issue 1, Pages (July 2011)
Volume 67, Issue 1, Pages (January 2015)
Volume 69, Issue 5, Pages (May 2016)
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Prostate Cancer: Highlights from 2006
Volume 72, Issue 5, Pages (November 2017)
Volume 60, Issue 1, Pages (July 2011)
Volume 57, Issue 6, Pages (June 2010)
Volume 51, Issue 4, Pages (April 2007)
European Urology Oncology
Volume 73, Issue 5, Pages (May 2018)
Volume 58, Issue 1, Pages (July 2010)
European Urology Oncology
Volume 61, Issue 2, Pages (February 2012)
Volume 59, Issue 6, Pages (June 2011)
Pitfalls of Pathologic Staging in Prostate Cancer
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal.
European Urology Oncology
Volume 68, Issue 3, Pages (September 2015)
Volume 67, Issue 3, Pages (March 2015)
Volume 59, Issue 4, Pages (April 2011)
Volume 69, Issue 6, Pages (June 2016)
European Urology Oncology
Volume 67, Issue 6, Pages (June 2015)
European Urology Oncology
Volume 71, Issue 5, Pages (May 2017)
European Urology Oncology
The PSA Era is not Over for Prostate Cancer
Volume 63, Issue 3, Pages (March 2013)
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer  I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
2005 Update on Pathology of Prostate Biopsies with Cancer
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography  Andrew.
Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective,
European Urology Oncology
Antonio Alcaraz, Pierre Teillac  European Urology Supplements 
European Urology Oncology
European Urology Oncology
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
European Urology Oncology
European Urology Oncology
Volume 49, Issue 6, Pages (June 2006)
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
European Urology Oncology
Volume 69, Issue 1, Pages (January 2016)
European Urology Oncology
European Urology Oncology
Volume 53, Issue 2, Pages (February 2008)
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Pathological Findings in TRUS Prostatic Biopsy—Diagnostic, Prognostic and Therapeutic Importance  Rodolfo Montironi, Roberta Mazzucchelli, Vincenzo Scattoni,
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
European Urology Oncology
2005 Update on Pathology of Prostate Biopsies with Cancer
European Urology Oncology
Maximilian Burger, Ashish M. Kamat, David McConkey 
Morgan Rouprêt, Per-Uno Malmstrom, Peter Black 
Presentation transcript:

European Urology Oncology Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer  Hanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, Noelia S. Salgado, Thenappan Chandrasekar, Zachary Klaassen, Christopher J.D. Wallis, Ali Hosni, Fabio Ynoe Moraes, Sangeet Ghai, Girish S. Kulkarni, Robert J. Hamilton, Nathan Perlis, Ants Toi, Peter Chung, Andrew Evans, Theo van der Kwast, Antonio Finelli, Neil Fleshner, Alejandro Berlin  European Urology Oncology  DOI: 10.1016/j.euo.2018.05.003 Copyright © 2018 Terms and Conditions

Fig. 1 Tumor extending into periprostatic fat on needle core biopsy and final radical prostatectomy specimen. (A) Low-magnification overview showing a prostate core biopsy that is extensively involved by adenocarcinoma. The box indicates the location of periprostatic fat on the end of the core. (B) Higher-magnification image of the box shown in A highlighting adenocarcinoma admixed with desmoplastic stroma and fat. (C) Low-magnification overview of a section from the right posterior quadrant collected during radical prostatectomy performed on the same patient. This section corresponds to the quadrant from which the biopsy was obtained. Note the lack of a well-defined histologic capsule between the prostate parenchyma and the extraprostatic soft tissue. (D) Higher-magnification image confirming the prostate biopsy diagnosis of extraprostatic extension, as indicated by adenocarcinoma in the plane of periprostatic fat. In addition, The presence of tumor showing perineural invasion within the periprostatic fat is evident (arrow). European Urology Oncology DOI: (10.1016/j.euo.2018.05.003) Copyright © 2018 Terms and Conditions

Fig. 2 (A) Metastasis-free survival and (B) biochemical recurrence-free survival in the entire cohort. (C) Metastasis-free survival and (D) biochemical recurrence-free survival stratified by treatment group (radical prostatectomy and radiotherapy). European Urology Oncology DOI: (10.1016/j.euo.2018.05.003) Copyright © 2018 Terms and Conditions